IOVANCE (IOVA) awards 15,000 restricted stock units to Chief Regulatory Officer Raj K. Puri

Rhea-AI Filing Summary

Puri Raj K. reported acquisition or exercise transactions in this Form 4 filing.

IOVANCE BIOTHERAPEUTICS, INC. granted Chief Regulatory Officer Raj K. Puri 15,000 restricted stock units, each representing one share of common stock. All 15,000 RSUs were reported as directly owned after the award. The grant vests over three years, with one-third vesting on the first anniversary of the grant date and the remaining units vesting in eight equal quarterly installments over the following two years, contingent on continued employment.

Insights

Equity compensation analyst

Routine RSU grant to officer, time-based vesting over three years.

The filing shows Raj K. Puri, Chief Regulatory Officer of IOVANCE BIOTHERAPEUTICS, INC., receiving 15,000 restricted stock units as a compensation award. Each RSU converts into one share of common stock at vesting, with no purchase price.

The award vests over three years: one-third on the first anniversary of the grant date, and the rest in eight equal quarterly installments over the next two years, subject to continued employment. This structure incentivizes retention and aligns the officer’s interests with long-term company performance, but does not involve any open-market buying or selling activity.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Puri Raj K.

Role Chief Regulatory Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	15,000	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 15,000 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
2. F2. Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.

Key Figures

RSUs granted: 15,000 units Shares per RSU: 1 share per unit Vesting term: 3 years +2 more

5 metrics

RSUs granted 15,000 units Restricted stock units awarded to Chief Regulatory Officer

Shares per RSU 1 share per unit Each RSU represents one share of common stock

Vesting term 3 years One-third after one year, balance in eight quarterly installments

Price per RSU $0.0000 No purchase price; compensation grant

Post-grant RSU holdings 15,000 units Total restricted stock units directly owned after transaction

Key Terms

Restricted Stock Units, RSU, vesting, contingent right, +1 more

5 terms

Restricted Stock Units financial

"security_title: "Restricted Stock Units" and related RSU grant details"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSU financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

vesting financial

"the RSUs shall vest over three years, with one-third vesting on the one-year anniversary"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

contingent right financial

"represents a contingent right to receive one share of the Issuer's common stock"

common stock financial

"underlying_security_title: "Common stock" and in the RSU footnote"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

What did IOVANCE BIOTHERAPEUTICS (IOVA) report in this Form 4?

IOVANCE reported a grant of 15,000 restricted stock units to Chief Regulatory Officer Raj K. Puri. Each RSU represents one share of common stock, awarded as equity compensation rather than a market purchase or sale.

Who received the RSU award disclosed by IOVANCE BIOTHERAPEUTICS (IOVA)?

Chief Regulatory Officer Raj K. Puri received the award. The Form 4 lists him as the reporting person and shows direct ownership of all 15,000 restricted stock units following the grant, reflecting a standard executive equity compensation grant.

How many restricted stock units were granted in this IOVA Form 4?

The filing shows a grant of 15,000 restricted stock units. Each unit corresponds to one share of IOVANCE common stock upon vesting, giving the officer potential ownership of 15,000 shares if all vesting conditions are satisfied.

What is the vesting schedule for Raj K. Puri’s IOVA RSU grant?

The RSUs vest over three years. One-third vests on the one-year anniversary of the grant date, and the remaining two-thirds vest in eight equal quarterly installments over the next two years, assuming continued employment with the company.

Does the IOVA Form 4 show any stock sales or purchases by Raj K. Puri?

No open-market stock sales or purchases are reported. The Form 4 only discloses a grant of 15,000 restricted stock units as a compensation award, with no exercise price or transaction price per share listed for the RSUs.

What does each IOVA restricted stock unit represent in this Form 4?

Each restricted stock unit represents a contingent right to receive one share of IOVANCE common stock. The units convert into shares as they vest over time, provided the officer remains employed through the applicable vesting dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/18/2026 - 05:15 PM Accepted by SEC EDGAR 06/18/2026 - 05:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Puri Raj K.

(Last) (First) (Middle)

C/O IOVANCE BIOTHERAPEUTICS, INC.

825 INDUSTRIAL ROAD, SUITE 100

(Street)

SAN CARLOS CALIFORNIA 94070

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IOVANCE BIOTHERAPEUTICS, INC. [ IOVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Regulatory Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	06/16/2026		A		15,000		(2)	(2)	Common stock	15,000	$0.00	15,000	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.

	/s/ Raj K. Puri	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)